Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss

Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with overweight or obesity compared to use of tirzepatide treatment alone, according to a study being presented Saturday at ENDO 2025, the Endocrine Society's annual meeting in San Francisco, Calif.
đ Full Story

Samsung Galaxy A56 5G Tips & Tricks! (Hidden Features)
- Kristi Noem Turns Tables After NBC Host Echoes Demsâ Freakout Over âAlligator Alcatrazâ - Hailey Gomez
- 6 Surprising Things That Are Increasing Your Stress Hormone (Cortisol) - Laura Schober
- Donald Trumpâs frustration with Vladimir Putin prompts shift of tone on Ukraine - MeighTimbol
- How to Use Trumpâs New Tax Cuts to Your Advantage Now
- INTERVIEW | David Verbeek and Jessica Reynolds: Navigating the Unspoken in âThe Wolf, the Fox, and the Leopardâ (TRIBECA) - Aayush Sharma
- Just 3 days left to save before TechCrunch All Stage 2025 lights up Boston - TechCrunch Events

I got scammed so you don't have to
- Drinking Sugar Could Be Worse For Your Health Than Eating It, New Study Suggests - Brian Mastroianni
- Our favorite smart air purifier is still available for $37 off in this Prime Day deal - Kris Holt
- Boat Migrants Arenât the Real Problem â So Why Is Britain Panicking? Fatima Drops a Shocking Bombshell on Live TV - Isaiah Amos
- Gemini can now turn your photos into video with Veo 3 - Ryan Whitwam
- Obesity-associated cancers tripled nationwide over past two decades
- Capcom shares first footage of Resident Evil mobile spinoff - Lawrence Bonk